Performance Measurement Network

Question: Lovenox 40mg daily - Antithrombotic Therapy Administered by End of Hospital Day Two

What is considered full dose lovenox? We are counting lovenox 40mg daily for DVT but are not counting that dose for Antithrombotic Therapy By End of Hospital Day 2. Is this correct?


The stroke measure specifications do not include drug dosages. However, if Lovenox 40mg is counted for STK-1 DVT prophylaxis, then it would not be included in STK-5 STK-2, or STK-3 because anticoagulants at doses to prevent DVT are insufficient antithrombotic therapy to prevent recurrent stroke or TIA.

Question Details
Focus area(s): Chart Abstracted Measure Specifications – Clinical, Related Manual - Data Quality Manual
Related documents: STK, Antithrombotic Therapy Administered by End of Hospital Day Two, ,

Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback
This website is using cookies. More info. That's Fine